IPC Drug Safety Alerts 2026: Levetiracetam, Xylometazoline and Oxymetazoline – Side Effects, Risks and Pharmacist Guidance
The Indian Pharmacopoeia Commission (IPC) has flagged three commonly used medicines for suspected adverse drug reactions (ADRs): levetiracetam, xylometazoline and oxymetazoline. The…
Read Article →


